Motor Imagery for Apraxia of Speech
(MI-TEE Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Motor Imagery for Treatment Enhancement and Efficacy (MI-TEE) for apraxia of speech?
Research on similar treatments for apraxia of speech, like the Phonomotor Treatment (PMT) and augmented feedback methods, shows that repeated practice and feedback can improve speech accuracy and maintain treatment effects over time. These findings suggest that using motor imagery, which involves mentally practicing movements, might also help enhance speech therapy outcomes by reinforcing motor planning and execution.12345
Is motor imagery safe for humans?
How does the Motor Imagery treatment for Apraxia of Speech differ from other treatments?
Motor Imagery for Apraxia of Speech is unique because it likely involves using mental visualization techniques to improve speech motor planning, which is different from traditional treatments that focus on physical speech practice or error reduction strategies. This approach may offer a novel way to engage the brain's motor pathways without direct speech production, potentially benefiting those who struggle with conventional methods.1351112
What is the purpose of this trial?
Treatment of post-stroke apraxia of speech (AOS) requires frequent and ongoing practice with a speech-language pathologist to facilitate lasting behavioral change, which is costly and, therefore, inaccessible to many patients. Thus, there is a critical need to identify novel, cost-effective ways to supplement speech therapy to increase opportunities for practice and optimize treatment outcomes. Our long-term goal is to develop an effective, home-practice, computer-based, motor imagery protocol Motor Imagery for Treatment Enhancement and Efficacy (MI-TEE) which will serve as an adjunct to routine speech therapy to optimize treatment response in persons with AOS. The overall objectives of this application are to (i) evaluate the acceptability and feasibility of MI-TEE as a home practice program and (ii) determine the efficacy of MI-TEE with speech therapy, compared to speech therapy alone, in improving speech production in people with AOS. Our central hypothesis is that MI-TEE will be an accessible, feasible, and efficacious adjunct to speech therapy. To attain our objectives, the following specific aims will be pursued using two single-subject experimental designs with multiple baselines across participants (n=18): 1) Evaluate the acceptability and feasibility of MI-TEE as an adjunct to speech therapy for the rehabilitation of AOS; and 2) Compare the efficacy of adjunctive MI-TEE plus standard speech therapy to standard speech therapy alone. Under the first aim, observational data, surveys, and semi-structured interviews will be employed to assess the acceptability (perceived satisfaction, appropriateness, and intent to continue use) and feasibility (recruitment, retention, and intervention adherence rates) of MI-TEE. For the second aim, accuracy of articulation for trained words and untrained words (generalization) will be measured pre-treatment, repeatedly during the treatment phase, and post-treatment. Improvements in speech accuracy will be documented using a binary scoring system (correct/incorrect). Multilevel analyses will be used to address rate of acquisition, overall change, and response variation across participants.
Research Team
Lauren Bislick Wilson, Ph.D.
Principal Investigator
University of Central Florida
Eligibility Criteria
This trial is for individuals with speech difficulties due to conditions like dyspraxia or apraxia, specifically those who have had a stroke. It's designed to help improve their speech production through regular practice and therapy.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Pre-treatment baseline testing to collect data points before treatment initiation
Treatment
Participants receive speech therapy 3 days a week for 8.3 weeks, with additional MI-TEE home practice sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment with follow-up probes at 2, 6, and 10 weeks
Treatment Details
Interventions
- Motor Imagery for Treatment Enhancement and Efficacy (MI-TEE)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Central Florida
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
National Institutes of Health (NIH)
Collaborator